Zhongdong Hu

1.2k citations
59 papers · 808 indexed · h-index 20
Topics
Cancer Mechanisms and Therapy (13 papers)PI3K/AKT/mTOR signaling in cancer (7 papers)Peptidase Inhibition and Analysis (6 papers)
Partner nations
ChinaMacaoHong Kong

In The Last Decade

Zhongdong Hu

52 papers receiving 797 citations

Peers

Zhongdong Hu
Comparison fields: 5 of 87
  • Molecular Biology 440
  • Cancer Research 167
  • Pathology and Forensic Medicine 146
  • Oncology 126
  • Immunology 97
Replace Weifeng Mao with:
Weifeng Mao China
Deok‐Beom Jung South Korea
Zhujun Tan China
Yung-Luen Shih Taiwan
Debra L. Bemis United States
Anusha Bishayee United States
Tae Woo Kim South Korea
Mahmoud Shekari Khaniani Iran
Pui–Kei Wu United States
Itishree Kaushik United States
Zhongdong Hu relative to Weifeng Mao China Weifeng Mao's profile →
Citations per field
00.5×1.5×1.8×
Weifeng Mao · 1×
Citations per year

Countries citing papers authored by Zhongdong Hu

Since Specialization
Citations

This map shows the geographic impact of Zhongdong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongdong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongdong Hu more than expected).

Fields of papers citing papers by Zhongdong Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongdong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongdong Hu. The network helps show where Zhongdong Hu may publish in the future.

Co-authorship network of co-authors of Zhongdong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongdong Hu. A scholar is included among the top collaborators of Zhongdong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongdong Hu. Zhongdong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 7
7 1
8 7
9 2
10 5
11 0
12 23
13 24
14 7
15 9
16 18
17 1
18 6
19 18
20 52

About Zhongdong Hu

Zhongdong Hu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 59 papers that have together received 808 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (13 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Cancer Research (167 citations), Pathology and Forensic Medicine (146 citations) and Toxicology (24 citations). Zhongdong Hu has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Ailin Yang, Pengfei Tu, Hongbing Zhang, Xiaojun Zha, Yanan Zhao, Yunfang Zhao, Xingyun Chai, Ying Wang, Guo‐Zhu Su and Peng Tan. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026